A simple phone call from a pharmacist, made regularly and patiently, is proving more powerful than many might expect at helping heart patients take control of their cholesterol. When 204 heart patients in west London received follow-up calls from the same pharmacist starting four to six weeks after their hospital admission, nearly three-quarters of them—70%—achieved healthy levels of LDL cholesterol, the dangerous kind that clogs arteries and triggers heart attacks and strokes.
The reason this matters is both obvious and urgent: many patients prescribed cholesterol-lowering medications like statins struggle to stay consistent with their treatment, leaving them vulnerable to another cardiovascular event. About a quarter of deaths in people with atherosclerotic cardiovascular disease are directly due to high cholesterol. Yet once patients leave the hospital, they often lack the ongoing support needed to understand their medications, reach their optimal doses, and maintain the discipline to take them as prescribed.
The research, presented at the British Cardiovascular Society conference in Manchester and led by Imperial College London, found something striking in the numbers themselves. The study participants started with an average LDL cholesterol level of 3.39 mmol per liter. After receiving pharmacist calls, this plummeted by 42% to 1.97 mmol per liter on average. That reduction translates to roughly a 33% lower risk of having another cardiovascular event, based on established medical evidence. For people who have already survived a heart attack, those odds matter profoundly.
What made the approach work was more than just reminders to take pills. The pharmacist—the same person calling each time, which allowed genuine relationships to develop—provided practical tips like pill organizers and medication apps. Crucially, patients received clear explanations of their cholesterol targets and why treatment mattered for their survival. The pharmacist also addressed fears head-on, informing patients about recent evidence showing that most reported statin side effects like muscle pain and sleep disruption are not actually caused by the drugs themselves, easing worries that had discouraged adherence.
All 204 participants in the study had been treated at Chelsea and Westminster Hospital NHS Foundation Trust and carried the diagnosis of atherosclerotic cardiovascular disease—fatty buildup in blood vessels that narrows or blocks blood flow. The majority had already experienced a heart attack. The intervention worked across all demographics: regardless of sex, ethnicity, or socioeconomic background, patients showed consistent improvement.
Dr. Sonya Babu-Narayan, the British Heart Foundation's clinical director and a consultant cardiologist, called the findings a glimpse of what focused support can achieve during what she termed "the golden window" right after patients return home from hospital. She noted that while the study didn't directly compare pharmacist calls to usual NHS care, a larger comparative study could be the logical next step—and that such a service might actually ease the burden on already-stretched general practitioners.
The research points toward a scalable solution to a widespread problem: patients leaving hospitals without the scaffolding they need to stick with life-saving medication. If pharmacist follow-up calls could be rolled out across the nation, the ripple effects could reshape how we support recovery after heart attacks and strokes. The evidence suggests that sometimes what saves lives isn't a new drug, but someone picking up the phone and believing in you enough to call again next week.